Equity Info – Page 383

Akzo Nobel India Ltd (AKZOINDIA)

📊 End of Day Bhavcopy

Date: 2025-09-09

Price: 3387.10
% Change: -0.97% (Prev Close: 3420.20)

Volume: 4,397
% Change: -73.51% (Prev Volume: 16,601)

Delivery: 2,018
Delivery % : 45.89
% Change: -77.69% (Prev Delivery: 9,045)

Turnover: 149 Lacs
% Change: -73.61% (Prev Turnover: 566)

💹 EOD Valuation

P/E Ratio: 38.09
P/B Ratio: 11.61
Market Cap: 15411 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: AKZOINDIA
Market Cap: 15532 Rs. Cr.
Face Value: 10.00 Rs.

52 Week High: 4674.00
52 Week Low: 3022.00

All-Time High: 4674.00 Rs.
All-Time Low: 214.05 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-8.61% | 4.13% | 2.56% | -5.27% | 20.15%

👥 Shareholding Pattern

Promoter Holding

Promoter Holding: 74.76%

Change (3Y | 1Y): 0.00% | 0.00%

Pledged %: 0.00%

FII Holding

FII Holding: 3.70%

Change (3Y | 1Y): 1.95% | 0.02%

DII Holding

DII Holding: 8.56%

Change (3Y | 1Y): -1.81% | 0.07%

Public Holding: 12.98%

🏦 Financial Strength

Debt to Equity: 0.05
Debt: 62.10 Rs. Cr.

Book Value: 291.76 Rs.
Current Ratio: 1.38
Interest Coverage: 54.79
Free Cash Flow: 204.30 Rs. Cr.

📈 Growth & Sales

Sales Growth: 1.28%

Sales Growth Qtr (YOY | QoQ):
-3.98% | -2.64%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
8.98% | 9.12% | 1.28%

💰 Profit & Earnings

Profit Growth %

Profit Growth: -6.12%

Profit Growth Qtr (YOY | QoQ):
-20.59% | -15.35%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
12.53% | 13.95% | -6.12%

EPS Rs.

EPS (TTM): 88.93 Rs.

EPS Qtr (Last Year | Latest):
25.16 Rs. | 19.98 Rs.

EPS Annual (Last Annual | Annual March):
93.70 Rs. | 94.11 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
12.53% | 13.95%

Net Profit Rs. Cr.

Net Profit (TTM): 405.00 Rs. Cr.

Net Profit (Annual - March): 428.60 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
114.60| 107.50 | 91.00

EBITDA Rs. Cr.

EBITDA (Quarter): 143.50 Rs. Cr.
EBITDA (Previous Yr Ql): 178.60 Rs. Cr.

EBITDA (Annual - March): 668.40 Rs. Cr.
EBITDA (Previous Annual): 669.00 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
10.19% | 13.56%

📊 Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 14.98%

OPM Qtr (Previous | Current):
15.56% | 13.52%

OPM Annual (5 Yrs | Last Yr | March):
14.80% | 15.98% | 15.69%

Return on Equity %

ROE: 32.23%

ROE (5 Yrs | 3 Yrs | Last Yr):
26.11% | 30.26% | 32.33%

Return on Capital Employed %

ROCE: 41.66%

ROCE (5 Yrs | 3 Yrs | Last Yr):
33.80% | 39.55% | 42.29%

Return on Assets %

ROA (TTM): 14.76%

ROA (5 Yrs | 3 Yrs | Last Yr):
12.49% | 14.17% | 15.15%

PEG Ratio: 2.75
Dividend Yield: 2.93%

PE 3 Yrs: 33.89
PE 5 Yrs: 33.87

Dividend Yield: 2.93%

👥 Company

Akzo Nobel India Ltd

AKZOINDIA

Promoter Holding: %

Alembic Pharmaceuticals Ltd (APLLTD)

📊 End of Day Bhavcopy

Date: 2025-09-09

Price: 936.00
% Change: -0.80% (Prev Close: 943.55)

Volume: 73,236
% Change: 50.24% (Prev Volume: 48,747)

Delivery: 25,730
Delivery % : 35.13
% Change: 25.39% (Prev Delivery: 20,520)

Turnover: 689 Lacs
% Change: 49.13% (Prev Turnover: 462)

💹 EOD Valuation

P/E Ratio: 30.51
P/B Ratio: 3.54
Market Cap: 18402 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: APLLTD
Market Cap: 18417 Rs. Cr.
Face Value: 2.00 Rs.

52 Week High: 1303.90
52 Week Low: 725.20

All-Time High: 1303.90 Rs.
All-Time Low: 31.00 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
0.98% | -3.22% | 13.15% | -14.37% | 14.30%

👥 Shareholding Pattern

Promoter Holding

Promoter Holding: 69.67%

Change (3Y | 1Y): 0.06% | 0.00%

Pledged %: 0.00%

FII Holding

FII Holding: 3.96%

Change (3Y | 1Y): -1.98% | 0.02%

DII Holding

DII Holding: 16.46%

Change (3Y | 1Y): 4.31% | 0.03%

Public Holding: 9.91%

🏦 Financial Strength

Debt to Equity: 0.24
Debt: 1257.50 Rs. Cr.

Book Value: 264.09 Rs.
Current Ratio: 1.69
Interest Coverage: 9.16
Free Cash Flow: -465.90 Rs. Cr.

📈 Growth & Sales

Sales Growth: 8.20%

Sales Growth Qtr (YOY | QoQ):
9.54% | -3.33%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
7.69% | 7.94% | 8.20%

💰 Profit & Earnings

Profit Growth %

Profit Growth: -5.85%

Profit Growth Qtr (YOY | QoQ):
14.60% | -1.92%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
-7.96% | 3.18% | -5.85%

EPS Rs.

EPS (TTM): 30.68 Rs.

EPS Qtr (Last Year | Latest):
6.85 Rs. | 7.85 Rs.

EPS Annual (Last Annual | Annual March):
31.33 Rs. | 29.68 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
-8.73% | 3.18%

Net Profit Rs. Cr.

Net Profit (TTM): 601.10 Rs. Cr.

Net Profit (Annual - March): 582.01 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
134.54| 156.63 | 153.63

EBITDA Rs. Cr.

EBITDA (Quarter): 287.40 Rs. Cr.
EBITDA (Previous Yr Ql): 239.25 Rs. Cr.

EBITDA (Annual - March): 1047.34 Rs. Cr.
EBITDA (Previous Annual): 957.36 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
-3.10% | 4.17%

📊 Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 15.42%

OPM Qtr (Previous | Current):
15.33% | 16.42%

OPM Annual (5 Yrs | Last Yr | March):
17.01% | 14.97% | 15.11%

Return on Equity %

ROE: 11.38%

ROE (5 Yrs | 3 Yrs | Last Yr):
13.45% | 10.61% | 13.34%

Return on Capital Employed %

ROCE: 13.05%

ROCE (5 Yrs | 3 Yrs | Last Yr):
14.13% | 11.20% | 13.14%

Return on Assets %

ROA (TTM): 7.99%

ROA (5 Yrs | 3 Yrs | Last Yr):
9.67% | 7.63% | 9.71%

PEG Ratio: 9.76
Dividend Yield: 1.17%

PE 3 Yrs: 33.33
PE 5 Yrs: 29.07

Dividend Yield: 1.17%

👥 Company

Alembic Pharmaceuticals Ltd

APLLTD

Promoter Holding: %

Alivus Life Sciences Ltd (ALIVUS)

📊 End of Day Bhavcopy

Date: 2025-09-09

Price: 953.00
% Change: 3.25% (Prev Close: 923.00)

Volume: 77,686
% Change: 51.55% (Prev Volume: 51,260)

Delivery: 36,998
Delivery % : 47.63
% Change: 16.87% (Prev Delivery: 31,658)

Turnover: 732 Lacs
% Change: 54.80% (Prev Turnover: 473)

💹 EOD Valuation

P/E Ratio: 23.56
P/B Ratio: 4.14
Market Cap: 11693 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: ALIVUS
Market Cap: 11591 Rs. Cr.
Face Value: 2.00 Rs.

52 Week High: 1335.10
52 Week Low: 827.10

All-Time High: 1335.10 Rs.
All-Time Low: 369.00 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-5.00% | -6.83% | -13.12% | -12.82% | 28.92%

👥 Shareholding Pattern

Promoter Holding

Promoter Holding: 74.94%

Change (3Y | 1Y): -7.91% | -0.05%

Pledged %: 0.00%

FII Holding

FII Holding: 6.42%

Change (3Y | 1Y): -1.16% | -0.15%

DII Holding

DII Holding: 5.62%

Change (3Y | 1Y): 4.83% | 0.43%

Public Holding: 13.03%

🏦 Financial Strength

Debt to Equity: 0.02
Debt: 56.61 Rs. Cr.

Book Value: 229.92 Rs.
Current Ratio: 3.95
Interest Coverage: 202.48
Free Cash Flow: 225.96 Rs. Cr.

📈 Growth & Sales

Sales Growth: 4.65%

Sales Growth Qtr (YOY | QoQ):
2.25% | -7.34%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
9.20% | 3.98% | 4.65%

💰 Profit & Earnings

Profit Growth %

Profit Growth: 10.91%

Profit Growth Qtr (YOY | QoQ):
9.02% | -14.33%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
8.92% | 4.71% | 10.91%

EPS Rs.

EPS (TTM): 40.45 Rs.

EPS Qtr (Last Year | Latest):
9.10 Rs. | 9.91 Rs.

EPS Annual (Last Annual | Annual March):
38.43 Rs. | 39.63 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
-52.37% | 4.71%

Net Profit Rs. Cr.

Net Profit (TTM): 495.69 Rs. Cr.

Net Profit (Annual - March): 485.63 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
111.48| 141.87 | 121.54

EBITDA Rs. Cr.

EBITDA (Quarter): 181.30 Rs. Cr.
EBITDA (Previous Yr Ql): 164.98 Rs. Cr.

EBITDA (Annual - March): 711.36 Rs. Cr.
EBITDA (Previous Annual): 686.99 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
7.95% | 4.05%

📊 Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 28.97%

OPM Qtr (Previous | Current):
30.55% | 28.63%

OPM Annual (5 Yrs | Last Yr | March):
29.62% | 29.56% | 28.67%

Return on Equity %

ROE: 18.69%

ROE (5 Yrs | 3 Yrs | Last Yr):
24.66% | 20.56% | 21.09%

Return on Capital Employed %

ROCE: 24.92%

ROCE (5 Yrs | 3 Yrs | Last Yr):
44.40% | 27.64% | 28.11%

Return on Assets %

ROA (TTM): 15.37%

ROA (5 Yrs | 3 Yrs | Last Yr):
17.62% | 16.81% | 16.98%

PEG Ratio: 4.96
Dividend Yield: 0.53%

PE 3 Yrs: 19.12
PE 5 Yrs: 15.35

Dividend Yield: 0.53%

👥 Company

Alivus Life Sciences Ltd

ALIVUS

Promoter Holding: %

Alkem Laboratories Ltd (ALKEM)

📊 End of Day Bhavcopy

Date: 2025-09-09

Price: 5335.50
% Change: 0.39% (Prev Close: 5315.00)

Volume: 92,005
% Change: 131.70% (Prev Volume: 39,709)

Delivery: 65,729
Delivery % : 71.44
% Change: 207.09% (Prev Delivery: 21,404)

Turnover: 4,916 Lacs
% Change: 131.50% (Prev Turnover: 2,124)

💹 EOD Valuation

P/E Ratio: 27.92
P/B Ratio: 5.32
Market Cap: 63813 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: ALKEM
Market Cap: 63411 Rs. Cr.
Face Value: 2.00 Rs.

52 Week High: 6440.00
52 Week Low: 4491.65

All-Time High: 6440.00 Rs.
All-Time Low: 1152.50 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
7.54% | 8.83% | 11.69% | -14.75% | 20.36%

👥 Shareholding Pattern

Promoter Holding

Promoter Holding: 53.04%

Change (3Y | 1Y): -4.10% | -2.09%

Pledged %: 0.00%

FII Holding

FII Holding: 9.11%

Change (3Y | 1Y): 3.44% | -0.29%

DII Holding

DII Holding: 21.80%

Change (3Y | 1Y): 7.70% | 2.38%

Public Holding: 16.05%

🏦 Financial Strength

Debt to Equity: 0.12
Debt: 1380.90 Rs. Cr.

Book Value: 1002.37 Rs.
Current Ratio: 2.50
Interest Coverage: 22.78
Free Cash Flow: 1278.06 Rs. Cr.

📈 Growth & Sales

Sales Growth: 4.49%

Sales Growth Qtr (YOY | QoQ):
11.19% | 7.23%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
9.21% | 6.83% | 4.49%

💰 Profit & Earnings

Profit Growth %

Profit Growth: 5.83%

Profit Growth Qtr (YOY | QoQ):
19.92% | 107.17%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
13.93% | 9.30% | 5.83%

EPS Rs.

EPS (TTM): 191.07 Rs.

EPS Qtr (Last Year | Latest):
45.60 Rs. | 55.56 Rs.

EPS Annual (Last Annual | Annual March):
150.19 Rs. | 181.11 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
13.93% | 9.30%

Net Profit Rs. Cr.

Net Profit (TTM): 2333.05 Rs. Cr.

Net Profit (Annual - March): 2215.38 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
550.24| 322.39 | 667.91

EBITDA Rs. Cr.

EBITDA (Quarter): 875.54 Rs. Cr.
EBITDA (Previous Yr Ql): 728.95 Rs. Cr.

EBITDA (Annual - March): 3001.29 Rs. Cr.
EBITDA (Previous Annual): 2559.51 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
13.74% | 10.68%

📊 Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 19.86%

OPM Qtr (Previous | Current):
12.45% | 21.92%

OPM Annual (5 Yrs | Last Yr | March):
18.30% | 17.75% | 19.38%

Return on Equity %

ROE: 19.39%

ROE (5 Yrs | 3 Yrs | Last Yr):
18.76% | 17.28% | 19.56%

Return on Capital Employed %

ROCE: 20.38%

ROCE (5 Yrs | 3 Yrs | Last Yr):
18.72% | 17.91% | 19.68%

Return on Assets %

ROA (TTM): 13.30%

ROA (5 Yrs | 3 Yrs | Last Yr):
12.44% | 11.40% | 13.02%

PEG Ratio: 3.00
Dividend Yield: 0.85%

PE 3 Yrs: 33.61
PE 5 Yrs: 28.45

Dividend Yield: 0.85%

👥 Company

Alkem Laboratories Ltd

ALKEM

Promoter Holding: %

Alkyl Amines Chemicals Ltd (ALKYLAMINE)

📊 End of Day Bhavcopy

Date: 2025-09-09

Price: 2029.00
% Change: -0.10% (Prev Close: 2031.00)

Volume: 19,027
% Change: -53.58% (Prev Volume: 40,987)

Delivery: 9,545
Delivery % : 50.17
% Change: -51.91% (Prev Delivery: 19,850)

Turnover: 385 Lacs
% Change: -54.12% (Prev Turnover: 840)

💹 EOD Valuation

P/E Ratio: 55.57
P/B Ratio: 7.40
Market Cap: 10368 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: ALKYLAMINE
Market Cap: 10256 Rs. Cr.
Face Value: 2.00 Rs.

52 Week High: 2498.85
52 Week Low: 1508.00

All-Time High: 4749.00 Rs.
All-Time Low: 5.56 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-4.75% | 6.42% | 23.76% | -2.88% | -10.80%

👥 Shareholding Pattern

Promoter Holding

Promoter Holding: 72.03%

Change (3Y | 1Y): 0.03% | -0.01%

Pledged %: 0.00%

FII Holding

FII Holding: 3.26%

Change (3Y | 1Y): 0.98% | 0.03%

DII Holding

DII Holding: 2.60%

Change (3Y | 1Y): 1.34% | 0.42%

Public Holding: 22.11%

🏦 Financial Strength

Debt to Equity: 0.00
Debt: 5.52 Rs. Cr.

Book Value: 274.26 Rs.
Current Ratio: 2.57
Interest Coverage: 225.39
Free Cash Flow: 216.23 Rs. Cr.

📈 Growth & Sales

Sales Growth: 10.29%

Sales Growth Qtr (YOY | QoQ):
1.46% | 5.05%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
9.62% | 0.64% | 10.29%

💰 Profit & Earnings

Profit Growth %

Profit Growth: 26.14%

Profit Growth Qtr (YOY | QoQ):
1.17% | 7.43%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
-0.31% | -6.02% | 26.14%

EPS Rs.

EPS (TTM): 36.51 Rs.

EPS Qtr (Last Year | Latest):
9.56 Rs. | 9.67 Rs.

EPS Annual (Last Annual | Annual March):
29.12 Rs. | 36.39 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
-0.37% | -6.06%

Net Profit Rs. Cr.

Net Profit (TTM): 186.68 Rs. Cr.

Net Profit (Annual - March): 186.11 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
48.87| 46.02 | 49.44

EBITDA Rs. Cr.

EBITDA (Quarter): 84.53 Rs. Cr.
EBITDA (Previous Yr Ql): 83.80 Rs. Cr.

EBITDA (Annual - March): 321.16 Rs. Cr.
EBITDA (Previous Annual): 266.74 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
4.00% | -1.84%

📊 Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 18.29%

OPM Qtr (Previous | Current):
17.57% | 18.88%

OPM Annual (5 Yrs | Last Yr | March):
22.02% | 17.47% | 18.54%

Return on Equity %

ROE: 13.96%

ROE (5 Yrs | 3 Yrs | Last Yr):
20.97% | 15.63% | 12.29%

Return on Capital Employed %

ROCE: 18.66%

ROCE (5 Yrs | 3 Yrs | Last Yr):
30.33% | 20.98% | 16.45%

Return on Assets %

ROA (TTM): 11.05%

ROA (5 Yrs | 3 Yrs | Last Yr):
16.93% | 12.03% | 9.43%

PEG Ratio: -9.13
Dividend Yield: 0.50%

PE 3 Yrs: 61.49
PE 5 Yrs: 60.06

Dividend Yield: 0.50%

👥 Company

Alkyl Amines Chemicals Ltd

ALKYLAMINE

Promoter Holding: %